ArticleRomanian journal of ophthalmology
Short-term effects of antiglaucomatous topical medication on the ocular surface in Wistar rats.
Article in Romanian journal of ophthalmology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Topical treatment remains the first-line therapeutic approach for glaucoma, primarily aimed at reducing intraocular pressure (IOP), which is currently the only modifiable risk factor for the disease. However, while topical medications are effective in lowering IOP, they are also associated with a range of adverse effects. This study evaluated the short-term side effects of various topical glaucoma medications in Wistar rats with experimentally induced intraocular hypertension. A glaucoma model was established using saline solution and viscoelastic pre-filled syringes, followed by the application of different topical anti-glaucomatous agents to assess both efficacy and potential side effects. Five groups of Wistar rats were utilized: four groups received other treatments, while the fifth group served as a control, with no therapy administered. The rats were monitored for 21 days following the induction of elevated intraocular pressure (IOP) and the commencement of treatment. Preliminary results suggested that the number of drops administered per day might have a more significant impact on the outcomes than the presence or absence of preservatives in the eye drops.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.